Nebivolol Hydrochloride



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 37.5%
Hypertension 19.3%
Cardiac Failure Congestive 5.2%
Tachycardia 4.2%
Convulsion 3.1%
Type 2 Diabetes Mellitus 3.1%
Depression 2.6%
Affective Disorder 2.1%
Anaesthesia 2.1%
Arthralgia 2.1%
Blood Pressure 2.1%
Blood Triglycerides Increased 2.1%
Diabetes Mellitus 2.1%
Glaucoma 2.1%
Hypertensive Heart Disease 2.1%
Ingrowing Nail 2.1%
Ventricular Tachyarrhythmia 2.1%
Multiple Myeloma 1.6%
Prostate Cancer 1.6%
Asthma 1.0%
Drug Interaction 16.1%
Heart Rate Decreased 12.9%
Blood Pressure Increased 6.5%
Presyncope 6.5%
Steal Syndrome 6.5%
Ventricular Tachycardia 6.5%
Arterial Occlusive Disease 3.2%
Condition Aggravated 3.2%
Heart Rate Increased 3.2%
Insomnia 3.2%
Kidney Infection 3.2%
Labelled Drug-disease Interaction Medication Error 3.2%
Muscle Rupture 3.2%
Muscular Weakness 3.2%
Nervousness 3.2%
Oedema Peripheral 3.2%
Platelet Count Decreased 3.2%
Renal Failure Acute 3.2%
Suicide Attempt 3.2%
Thrombocytopenia 3.2%
Concomitant
Hypertension 32.0%
Drug Use For Unknown Indication 14.7%
Type 2 Diabetes Mellitus 13.0%
Coronary Artery Disease 7.7%
Product Used For Unknown Indication 5.1%
Rheumatoid Arthritis 5.1%
Hyperlipidaemia 2.9%
Cardiac Failure 2.2%
Atrial Fibrillation 2.1%
Hypercholesterolaemia 2.1%
Diabetes Mellitus 1.9%
Depression 1.5%
Dyslipidaemia 1.5%
Back Pain 1.4%
Hypothyroidism 1.4%
Nausea 1.4%
Type Iia Hyperlipidaemia 1.2%
Goitre 1.0%
Hyperuricaemia 1.0%
Osteoarthritis 0.9%
Rhabdomyolysis 9.2%
Hypertension 7.7%
Acute Myeloid Leukaemia 6.2%
Pancreatitis 6.2%
Renal Failure Acute 6.2%
Skin Exfoliation 6.2%
Vomiting 6.2%
Cerebrovascular Accident 4.6%
Death 4.6%
Liver Disorder 4.6%
Pulmonary Embolism 4.6%
Pulmonary Oedema 4.6%
Pyrexia 4.6%
Renal Failure 4.6%
Skin Necrosis 4.6%
Abdominal Pain Upper 3.1%
Acute Myelomonocytic Leukaemia 3.1%
Atrial Flutter 3.1%
Constipation 3.1%
Coronary Artery Disease 3.1%
Interacting
Drug Use For Unknown Indication 62.5%
Cardiac Failure 18.8%
Angina Pectoris 12.5%
Abdominal Discomfort 6.3%
Drug Interaction 25.0%
Speech Disorder 25.0%
Ventricular Tachycardia 25.0%
Vomiting 25.0%